Krystal Biotech

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$116,357
$107,105
$97,800
$96,042
Gross Profit
110,034
96,188
92,137
88,877
EBITDA
55,415
39,609
49,576
40,850
EBIT
53,689
37,844
47,967
39,307
Net Income
55,932
51,400
79,365
38,333
Net Change In Cash
116,357
107,105
97,800
96,042
Free Cash Flow
73,234
75,369
37,955
50,825
Cash
501,313
496,304
392,604
353,829
Basic Shares
30,507
29,951
29,833
29,749

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$389,130
$290,515
$50,699
$0
Gross Profit
360,357
270,454
47,605
-4,055
EBITDA
167,846
109,909
-91,316
-116,811
EBIT
161,295
103,195
-97,227
-120,196
Net Income
204,831
89,159
10,932
-139,975
Net Change In Cash
389,130
290,515
50,699
0
Free Cash Flow
188,914
119,182
-100,603
-153,548
Cash
496,304
344,865
358,328
161,900
Basic Shares
29,951
29,740
27,752
25,492

Earnings Calls

QuarterEPS
2026-03-31
$1.83
2025-12-31
$1.70
2025-09-30
$2.66
2025-06-30
$1.29